tiprankstipranks
Advertisement
Advertisement
SCYNEXIS Stockholders Approve One-for-Eight Reverse Split
PremiumCompany AnnouncementsSCYNEXIS Stockholders Approve One-for-Eight Reverse Split
1M ago
Scynexis announces 1-for-8 reverse stock split
Premium
The Fly
Scynexis announces 1-for-8 reverse stock split
1M ago
Buy Rating Reaffirmed on Scynexis as Rare Disease Pivot and Strong Cash Runway Support Unchanged $4 Price Target
Premium
Ratings
Buy Rating Reaffirmed on Scynexis as Rare Disease Pivot and Strong Cash Runway Support Unchanged $4 Price Target
2M ago
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
PremiumCompany AnnouncementsSCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
3M ago
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
Premium
Company Announcements
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
3M ago
SCYNEXIS Raises $40 Million in Strategic Private Placement
Premium
Company Announcements
SCYNEXIS Raises $40 Million in Strategic Private Placement
3M ago
Scynexis announces first patients dosed in Phase 1 SAD, MAD trial of SCY-247
PremiumThe FlyScynexis announces first patients dosed in Phase 1 SAD, MAD trial of SCY-247
4M ago
Cero Therapeutics appoints Eric Francois to board of directors
Premium
The Fly
Cero Therapeutics appoints Eric Francois to board of directors
5M ago
Scynexis announces presentation highlighting data from SCY-247
Premium
The Fly
Scynexis announces presentation highlighting data from SCY-247
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100